Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Mitomycin-C-Kyowa
Active Ingredient: Mitomycin 10mg
Dosage Form: Powder for injection
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer: Kyowa Hakko Kogyo Co Limited, Chiyoda-Ku, Tokyo, Japan
Note: This consent is valid for two years from the date of publication of this notice.
Product: Mitomycin-C-Kyowa
Active Ingredient: Mitomycin 2mg
Dosage Form: Powder for injection
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer: Kyowa Hakko Kogyo Co Limited, Chiyoda-Ku, Tokyo, Japan
Note: This consent is valid for two years from the date of publication of this notice.
Product: Mitomycin-C-Kyowa
Active Ingredient: Mitomycin 20mg
Dosage Form: Powder for injection
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer: Kyowa Hakko Kogyo Co Limited, Chiyoda-Ku, Tokyo, Japan
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 8th day of February 2008.
ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).